Evidence map›Paper›PMID 34240320›Full record

ArticleJournal of neurology2022

Cerebral mucormycosis: neuroimaging findings and histopathological correlation.

François Lersy, Julie Royer-Leblond, Benoit Lhermitte, Agathe Chammas, Francis Schneider, Yves Hansmann, Nicolas Lefebvre, Julie Denis, Marcela Sabou, François Lafitte and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Non-JHLT open · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 2 countries.

François Lersy *Service d'imagerie 2, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 1 avenue Molière 67200, Strasbourg, France.ORCID http://orcid.org/0000-0001-6018-4057
Julie Royer-Leblond *Service de Radiologie, Centre Hospitalier de Haguenau, Haguenau, France.
Benoit LhermitteDepartment of Pathology, Hautepierre University Hospital, 1 avenue Molière, 67200, Strasbourg, France.
Agathe ChammasService d'imagerie 2, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 1 avenue Molière 67200, Strasbourg, France.
Francis SchneiderService de Médecine-Intensive-Réanimation, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Yves HansmannService de Maladies Infectieuses, NHC, CHU de Strasbourg, Strasbourg, France.
Nicolas LefebvreService de Maladies Infectieuses, NHC, CHU de Strasbourg, Strasbourg, France.
Julie DenisCHU de Strasbourg, Laboratoire de Parasitologie Et de Mycologie Médicale, Plateau Technique de Microbiologie, 1 rue Koeberlé, 67000, Strasbourg, France.
Marcela SabouCHU de Strasbourg, Laboratoire de Parasitologie Et de Mycologie Médicale, Plateau Technique de Microbiologie, 1 rue Koeberlé, 67000, Strasbourg, France.
François LafitteRadiology Department, Rothschild Foundation in Paris, Paris, France.
François CottonService de Radiologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, Lyon, France.
Marie-Paule Boncoeur-MartelINSERM, U1094, Neuroépidémiologie Tropicale, Limoges, France.
Thomas TourdiasCHU de Bordeaux, Neuro imagerie diagnostique et thérapeutique, 33000, Bordeaux, France.
Jean-Pierre PruvoInserm U 1172, CHU de Lille, University of Lille, Lille, France.
Jean-Philippe CottierService de Radiologie, CHU Tours, Tours, France.
Raoul HerbrechtDepartment of Hematology, Institut de Cancérologie Strasbourg.Europe (ICANS) and Université de Strasbourg, Inserm UMR-S1113/IRFAC, Strasbourg, France.
Stéphane KremerService d'imagerie 2, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, 1 avenue Molière 67200, Strasbourg, France. stephane.kremer@chru-strasbourg.fr.
Hôpitaux Universitaires de Strasbourg · FRInserm · FRCentre Hospitalier Universitaire de Tours · FRCentre National de la Recherche Scientifique · FRFondation de Rothschild · FRHôpital d'Hautepierre · FRInstitut de Virologie · FRUniversité Claude Bernard Lyon 1 · FRUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMucormycosis are infections caused by molds of the order Mucorales. These opportunistic infections are rare, difficult to diagnose, and have a poor prognosis. We aimed to describe common radiographic patterns that may help to diagnose cerebral mucormycosis and search for histopathological correlations with imaging data.

methodsWe studied the radiological findings (CT and MRI) of 18 patients with cerebral mucormycosis and four patients' histopathological findings.

resultsAll patients were immunocompromised and/or diabetic. The type of lesions depended on the infection's dissemination pathway. Hematogenous dissemination lesions were most frequently abscesses (59 lesions), cortical, cortical-subcortical, or in the basal ganglia, with a halo aspect on DWI for lesions larger than 1.6 cm. Only seven lesions were enhanced after contrast injection, with different presentations depending on patients' immune status. Ischemia and hemorrhagic areas were also seen. Vascular lesions were represented by stenosis and thrombosis. Direct posterior extension lesions were bi-fronto basal hypodensities on CT and restricted diffusion without enhancement on MRI. A particular extension, perineural spread, was seen along the trigeminal nerve. Histopathological analysis found endovascular lesions with destruction of vessel walls by Mucorales, microbleeds around vessels, as well as acute and chronic inflammation.

conclusionsMRI is the critical exam for cerebral mucormycosis. Weak ring enhancement and reduced halo diffusion suggest the diagnosis of fungal infections. Involvement of the frontal lobes should raise suspicion of mucormycosis (along with aspergillosis). The perineural spread can be considered a more specific extension pathway of mucormycosis.

Indexed as

MucormycosisHumansImmunocompromised HostMagnetic Resonance ImagingNeuroimagingCerebral mucormycosisFungalInvasive fungal infectionsMRIMucormycosis

Identifiers

PMID34240320
OpenAlexW3178621815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.